Sequential chemotherapy and radiotherapy for initial management of Stage IIIA and Stage IIIB non-small cell lung cancer — induction chemotherapy-Reference-Cited by-同舟云学术

Sequential chemotherapy and radiotherapy for initial management of Stage IIIA and Stage IIIB non-small cell lung cancer — induction chemotherapy

Published:1991-04 Issue:1-2 Volume:7 Page:77-84
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Green Mark R.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference22 articles.

1. Protochemotherapy in non-small cell lung carcinoma;Bitran;Cancer,1986

2. Cisplatin and vinblastine chemotherapy for metastatic non-small cell lung carcinoma followed by irradiation in patients with regional disease;Blum;Cancer Treat Rep,1986

3. Toxicity and induction chemotherapy response data for combined chemotherapy/radiotherapy in limited stage III non-small cell lung cancer;Clamon,1990

4. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the RTOG;Cox;Cancer Treat Rep,1986

5. Protochemotherapy improves survival in regional non-small cell lung cancer;Dillman,1988

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung;Lung Cancer;2000-01

2. Multimodality therapy in unresected stage iii non-small cell lung cancer: the american cooperative groups' experience;Lung Cancer;1995-04

3. The role of induction chemotherapy before radiation therapy in non-operative management of Stage III NSCLC;Lung Cancer;1994-11

4. Does adjuvant chemotherapy decrease distant metastasis formation in patients with non-small cell lung cancer?;Lung Cancer;1994-03

5. Treatment evaluation of combined modality therapy: ‘What can we obtain today from Phase II trials?’;Lung Cancer;1994-03